Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency ARHCC Library REF | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library REF | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library REF | Available |
c.1 BC Cancer Agency ARHCC Library REF | Available | ||
c.1 BC Cancer Agency KEL Library REF | Available | ||
c.1 BC Cancer Agency SUR Library REF | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library REF | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library REF | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |
Content:; PART 1: Introduction -- PART 2: Tumor Biology -- PART 3: Quantitative Oncology -- PART 4: Carcinogenesis -- PART 5: Epidemiology, Prevention, and Detection -- PART 6: Clinical Disciplines -- PART 7: Individualized Treatment -- PART 8: Chemotherapy -- PART 9: Biological and Gene Therapy --…
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; Chapter 1 -- Considerations of Novel Diagnostic and Therapeutic Approaches to Metastatic Triple-Negative Breast Cancer -- Correlations of Germline BRCA Mutations with TNBC ? Taking Advantage of ?Vulnerable? Tumors -- Mutations in BRCA Genes and PD-L1?expression on the Immune Cells - As I…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Head and neck tumours; Digestive system tumours; Lung and pleural tumours; Bone and soft tissue tumours; Skin tumours; Breast tumours; Gynaecological tumours; Urological tumours; Adrenal cortex tumours; Ophthalmic tumours; Hodgkin lymphoma; Non-Hodgkin lymphomas
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library REF | Available | ||
c.1 BC Cancer Agency SUR Library REF | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library REF | Available |